Variational AI uses generative AI to enhance small molecule drug discovery for biopharmaceutical companies.

HD is a Thailand-based healthcare startup that operates a marketplace platform, HDmall, which aggregates healthcare services to lower costs and offers installment payment options in Thailand and Indonesia.

Ambrosia Biosciences develops orally delivered, small molecule-based therapies for obesity and metabolic disorders.

DANNCE.AI develops AI-driven digital phenotyping platforms that create 3D reconstructions of patient movements from video data for clinical diagnostics and monitoring.

Qure.ai develops AI-driven solutions for early disease detection and has deployed its technology globally.

Unnatural Products is a biotech company that develops AI-driven synthetic molecules for targeted therapeutics, with a focus on expanding beyond oncology.

Culmination Bio is a health data analytics firm that provides a disease-agnostic patient data intelligence platform, leveraging a large library of de-identified patient electronic health records and biospecimen data to aid biopharmaceutical companies in diagnostic and therapeutic development.

Pepper Bio is a transomics-driven drug discovery startup working to enhance the drug development process by integrating multi-layered biological data to address oncology challenges and reduce failure rates in drug discovery.

AeroSafe Global is a New York-based cold chain solution provider specializing in biopharmaceutical cold chain services, offering reusable thermal packaging, outsourced supply chain services, and temperature monitoring to ensure safe and effective delivery of pharmaceuticals to patients, providers, pharmacies, and hospital systems worldwide.